Eagle Pharmaceutical (EGRX) 46.57 $EGRX
SHAREHOLDER ALERT: Rosen Law Firm Reminds Eagle Pharmaceuticals, Inc. Investors of Important August 1 Deadline in Class Action - EGRX
GlobeNewswire - Mon Aug 01, 6:00PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Eagle Pharmaceuticals, Inc. securities (NASDAQ:EGRX) from February 23, 2016 through March 18, 2016, both dates inclusive (the "Class Period"
of the important August 1, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Eagle Pharmaceuticals investors under the federal securities laws.
EGRX: 46.57 (+3.43)
EGRX Investors: The Wagner Firm Announces The Filing Of A Securities Class Action On Behalf of Eagle Pharmaceuticals Inc. Investors
BusinessWire - Mon Aug 01, 12:40PM CDT
The Wagner Firm announces the filing of a class action lawsuit on behalf of investors who purchased Eagle Pharmaceuticals Inc. ("Eagle" or the "Company" (NASDAQ: EGRX) securities between February 23, 2016 and March 18, 2016, inclusive (the "Class Period". Eagle investors have until August 1, 2016 to file a lead plaintiff motion.
EGRX: 46.57 (+3.43)
3-DAY DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Eagle Pharmaceuticals Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Jul 29, 10:59AM CDT
LOS ANGELES, CA / ACCESSWIRE / July 29, 2016 / Lundin Law PC (the "Firm" announces a class action lawsuit has been filed against Eagle Pharmaceuticals Inc. ("Eagle" or the "Company" (NASDAQ: EGRX) concerning possible violations of federal securities laws between February 23, 2016 and March 18, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 1, 2016 lead plaintiff motion deadline.
EGRX: 46.57 (+3.43)
UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 1, 2016 - EGRX
PR Newswire - Fri Jul 29, 8:27AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
EGRX: 46.57 (+3.43)
INVESTOR NOTICE: Goldberg Law PC Announces Securities Class Action Lawsuit against Eagle Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
BusinessWire - Tue Jul 26, 1:35PM CDT
Goldberg Law PC (www.Goldberglawpc.com) announces that a class action lawsuit has been filed against Eagle Pharmaceuticals, Inc. ("Eagle" or the "Company" (Nasdaq: EGRX). Investors who purchased or otherwise acquired shares between February 23, 2016 and March 18, 2016 (the "Class Period" are encouraged to contact the firm in advance of the August 1, 2016 lead plaintiff motion deadline.
EGRX: 46.57 (+3.43)
August 1 Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of the Upcoming Deadline in the Class Action Lawsuit Against Eagle Pharmaceuticals Inc.
BusinessWire - Tue Jul 26, 11:20AM CDT
Law Offices of Howard G. Smith reminds investors of the upcoming August 1, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of a class (the "Class" of investors who purchased Eagle Pharmaceuticals Inc. ("Eagle" or the "Company" (NASDAQ: EGRX) securities between February 23, 2016 and March 18, 2016, inclusive (the "Class Period". Eagle investors have until August 1, 2016 to file a lead plaintiff motion.
EGRX: 46.57 (+3.43)
APPROACHING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Eagle Pharmaceuticals Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Tue Jul 26, 10:43AM CDT
IRVINE, CA / ACCESSWIRE / July 26, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit was filed against Eagle Pharmaceuticals Inc. ("Eagle" or the "Company" (NASDAQ: EGRX). Investors who purchased or otherwise acquired shares between February 23, 2016 and March 18, 2016 (the "Class Period", are encouraged to contact the Firm prior to the August 1, 2016 lead plaintiff motion deadline.
EGRX: 46.57 (+3.43)
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Lawsuit Involving Eagle Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of August 1, 2016 - EGRX
GlobeNewswire - Tue Jul 26, 9:05AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) securities between February 23, 2016 through March 18, 2016.
EGRX: 46.57 (+3.43)
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Eagle Pharmaceuticals, Inc. - EGRX
GlobeNewswire - Mon Jul 18, 5:48PM CDT
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Eagle Pharmaceuticals, Inc. securities (NASDAQ:EGRX) from February 23, 2016 through March 18, 2016, both dates inclusive (the "Class Period". The lawsuit seeks to recover damages for Eagle Pharmaceuticals investors under the federal securities laws.
EGRX: 46.57 (+3.43)
IMPORTANT SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Eagle Pharmaceuticals Inc. And Reminds Investors with Losses To Contact The Firm
BusinessWire - Mon Jul 18, 11:29AM CDT
Lundin Law PC announces a class action lawsuit has been filed against Eagle Pharmaceuticals Inc. ("Eagle" or the "Company" (Nasdaq: EGRX) concerning possible violations of federal securities laws between February 23, 2016 and March 18, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 1, 2016 lead plaintiff motion deadline.
EGRX: 46.57 (+3.43)
INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Eagle Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of August 1, 2016 - EGRX
PR Newswire - Fri Jul 08, 10:06AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) securities between February 23, 2016 through March 18, 2016.
EGRX: 46.57 (+3.43)
IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Eagle Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
BusinessWire - Wed Jun 22, 4:51PM CDT
Goldberg Law PC (www.Goldberglawpc.com) announces that a class action lawsuit has been filed against Eagle Pharmaceuticals, Inc. ("Eagle Pharmaceuticals" or the "Company" (Nasdaq: EGRX). Investors who purchased or otherwise acquired shares between February 23, 2016 and March 18, 2016 (the "Class Period", are encouraged to contact the firm in advance of the August 1, 2016, lead plaintiff motion deadline.
EGRX: 46.57 (+3.43)
INVESTOR ALERT: Investigation of Eagle Pharmaceuticals Inc. Announced by Law Offices of Howard G. Smith
BusinessWire - Wed Jun 22, 1:39PM CDT
Law Offices of Howard G. Smith announces an investigation on behalf of investors of Eagle Pharmaceuticals Inc. ("Eagle" or the "Company" (NASDAQ: EGRX) concerning the Company and its officers' possible violations of federal securities laws.
EGRX: 46.57 (+3.43)
EAGLE PHARMACEUTICALS INVESTOR ALERT: Hagens Berman Reminds Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) Investors of August 1, 2016 Lead Plaintiff Deadline in Securities Class Action
GlobeNewswire - Tue Jun 21, 3:00AM CDT
The following statement is being issued by Hagens Berman Sobol Shapiro LLP:
EGRX: 46.57 (+3.43)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 1, 2016 - EGRX
GlobeNewswire - Mon Jun 20, 10:51AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
EGRX: 46.57 (+3.43)
Lifshitz & Miller Law Firm Announces Investigation of CBL & Associates Properties, Inc., Eagle Pharmaceuticals, Inc., HCP, Inc., Immunomedics, Inc., Infinity Pharmaceuticals Inc., Neovasc, Inc., and Unilife Corporation
PR Newswire - Fri Jun 17, 6:09PM CDT
CBL & Associates Properties, Inc. (CBL)Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the CBL board. Specifically, on May 24, 2016, the Wall Street Journal reported investigations concerning CBL officials falsifying information on financial statements to banks when applying for financial arrangements.
IMMU: 2.80 (+0.15), HCP: 39.45 (+0.22), UNIS: 3.48 (-0.06), CBL: 12.19 (-0.10), INFI: 1.69 (+0.01), EGRX: 46.57 (+3.43), NVCN: 0.58 (+0.04)
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Eagle Pharmaceuticals, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 1, 2016 - EGRX
ACCESSWIRE - Wed Jun 15, 9:04AM CDT
NEW YORK, NY / ACCESSWIRE / June 15, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
EGRX: 46.57 (+3.43)
Law Offices of Marc S. Henzel Announces Investigation of Companies for Violations of the Federal Securities Laws
PR Newswire - Tue Jun 14, 8:11AM CDT
The Law Offices of Marc S. Henzel (www.henzellaw.com), a firm focusing on shareholder litigation, gives notice to shareholders of investigation into the following securities for violations of the Federal Securities Laws:
LDRH: 36.98 (-0.02), CBL: 12.19 (-0.10), TRXC: 1.30 (-0.05), EGRX: 46.57 (+3.43), NVCN: 0.58 (+0.04)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Eagle Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - EGRX
PR Newswire - Fri Jun 10, 4:42PM CDT
Pomerantz LLP announces that a class action lawsuit has been against Eagle Pharmaceuticals, Inc. ("Eagle Pharmaceuticals" or the "Company" (NASDAQ: EGRX) and certain of its officers. The class action, filed in United States District Court, District of New Jersey, and docketed under 16-cv-03091, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Eagle Pharmaceuticals securities between February 23, 2016 and March 18, 2016 inclusive (the "Class Period". This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act".
EGRX: 46.57 (+3.43)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Eagle Pharmaceuticals, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 1, 2016 -- EGRX
Marketwired - Fri Jun 10, 11:37AM CDT
NEW YORK, NY--(Marketwired - June 10, 2016) - The following statement is being issued by Levi & Korsinsky, LLP:
EGRX: 46.57 (+3.43)
SHAREHOLDER ALERT: Rosen Law Firm Reminds Eagle Pharmaceuticals, Inc. Investors of Important August 1 Deadline in Class Action - EGRX
GlobeNewswire - Mon Aug 01, 6:00PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Eagle Pharmaceuticals, Inc. securities (NASDAQ:EGRX) from February 23, 2016 through March 18, 2016, both dates inclusive (the "Class Period"
of the important August 1, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Eagle Pharmaceuticals investors under the federal securities laws. EGRX: 46.57 (+3.43)
EGRX Investors: The Wagner Firm Announces The Filing Of A Securities Class Action On Behalf of Eagle Pharmaceuticals Inc. Investors
BusinessWire - Mon Aug 01, 12:40PM CDT
The Wagner Firm announces the filing of a class action lawsuit on behalf of investors who purchased Eagle Pharmaceuticals Inc. ("Eagle" or the "Company"
(NASDAQ: EGRX) securities between February 23, 2016 and March 18, 2016, inclusive (the "Class Period". Eagle investors have until August 1, 2016 to file a lead plaintiff motion. EGRX: 46.57 (+3.43)
3-DAY DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Eagle Pharmaceuticals Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Jul 29, 10:59AM CDT
LOS ANGELES, CA / ACCESSWIRE / July 29, 2016 / Lundin Law PC (the "Firm"
announces a class action lawsuit has been filed against Eagle Pharmaceuticals Inc. ("Eagle" or the "Company" (NASDAQ: EGRX) concerning possible violations of federal securities laws between February 23, 2016 and March 18, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 1, 2016 lead plaintiff motion deadline. EGRX: 46.57 (+3.43)
UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 1, 2016 - EGRX
PR Newswire - Fri Jul 29, 8:27AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
EGRX: 46.57 (+3.43)
INVESTOR NOTICE: Goldberg Law PC Announces Securities Class Action Lawsuit against Eagle Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
BusinessWire - Tue Jul 26, 1:35PM CDT
Goldberg Law PC (www.Goldberglawpc.com) announces that a class action lawsuit has been filed against Eagle Pharmaceuticals, Inc. ("Eagle" or the "Company"
(Nasdaq: EGRX). Investors who purchased or otherwise acquired shares between February 23, 2016 and March 18, 2016 (the "Class Period" are encouraged to contact the firm in advance of the August 1, 2016 lead plaintiff motion deadline. EGRX: 46.57 (+3.43)
August 1 Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of the Upcoming Deadline in the Class Action Lawsuit Against Eagle Pharmaceuticals Inc.
BusinessWire - Tue Jul 26, 11:20AM CDT
Law Offices of Howard G. Smith reminds investors of the upcoming August 1, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of a class (the "Class"
of investors who purchased Eagle Pharmaceuticals Inc. ("Eagle" or the "Company" (NASDAQ: EGRX) securities between February 23, 2016 and March 18, 2016, inclusive (the "Class Period". Eagle investors have until August 1, 2016 to file a lead plaintiff motion. EGRX: 46.57 (+3.43)
APPROACHING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Eagle Pharmaceuticals Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Tue Jul 26, 10:43AM CDT
IRVINE, CA / ACCESSWIRE / July 26, 2016 / Khang & Khang LLP (the "Firm"
announces that a class action lawsuit was filed against Eagle Pharmaceuticals Inc. ("Eagle" or the "Company" (NASDAQ: EGRX). Investors who purchased or otherwise acquired shares between February 23, 2016 and March 18, 2016 (the "Class Period", are encouraged to contact the Firm prior to the August 1, 2016 lead plaintiff motion deadline. EGRX: 46.57 (+3.43)
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Lawsuit Involving Eagle Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of August 1, 2016 - EGRX
GlobeNewswire - Tue Jul 26, 9:05AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) securities between February 23, 2016 through March 18, 2016.
EGRX: 46.57 (+3.43)
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Eagle Pharmaceuticals, Inc. - EGRX
GlobeNewswire - Mon Jul 18, 5:48PM CDT
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Eagle Pharmaceuticals, Inc. securities (NASDAQ:EGRX) from February 23, 2016 through March 18, 2016, both dates inclusive (the "Class Period"
. The lawsuit seeks to recover damages for Eagle Pharmaceuticals investors under the federal securities laws. EGRX: 46.57 (+3.43)
IMPORTANT SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Eagle Pharmaceuticals Inc. And Reminds Investors with Losses To Contact The Firm
BusinessWire - Mon Jul 18, 11:29AM CDT
Lundin Law PC announces a class action lawsuit has been filed against Eagle Pharmaceuticals Inc. ("Eagle" or the "Company"
(Nasdaq: EGRX) concerning possible violations of federal securities laws between February 23, 2016 and March 18, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 1, 2016 lead plaintiff motion deadline. EGRX: 46.57 (+3.43)
INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Eagle Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of August 1, 2016 - EGRX
PR Newswire - Fri Jul 08, 10:06AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) securities between February 23, 2016 through March 18, 2016.
EGRX: 46.57 (+3.43)
IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Eagle Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
BusinessWire - Wed Jun 22, 4:51PM CDT
Goldberg Law PC (www.Goldberglawpc.com) announces that a class action lawsuit has been filed against Eagle Pharmaceuticals, Inc. ("Eagle Pharmaceuticals" or the "Company"
(Nasdaq: EGRX). Investors who purchased or otherwise acquired shares between February 23, 2016 and March 18, 2016 (the "Class Period", are encouraged to contact the firm in advance of the August 1, 2016, lead plaintiff motion deadline. EGRX: 46.57 (+3.43)
INVESTOR ALERT: Investigation of Eagle Pharmaceuticals Inc. Announced by Law Offices of Howard G. Smith
BusinessWire - Wed Jun 22, 1:39PM CDT
Law Offices of Howard G. Smith announces an investigation on behalf of investors of Eagle Pharmaceuticals Inc. ("Eagle" or the "Company"
(NASDAQ: EGRX) concerning the Company and its officers' possible violations of federal securities laws. EGRX: 46.57 (+3.43)
EAGLE PHARMACEUTICALS INVESTOR ALERT: Hagens Berman Reminds Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) Investors of August 1, 2016 Lead Plaintiff Deadline in Securities Class Action
GlobeNewswire - Tue Jun 21, 3:00AM CDT
The following statement is being issued by Hagens Berman Sobol Shapiro LLP:
EGRX: 46.57 (+3.43)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 1, 2016 - EGRX
GlobeNewswire - Mon Jun 20, 10:51AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
EGRX: 46.57 (+3.43)
Lifshitz & Miller Law Firm Announces Investigation of CBL & Associates Properties, Inc., Eagle Pharmaceuticals, Inc., HCP, Inc., Immunomedics, Inc., Infinity Pharmaceuticals Inc., Neovasc, Inc., and Unilife Corporation
PR Newswire - Fri Jun 17, 6:09PM CDT
CBL & Associates Properties, Inc. (CBL)Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the CBL board. Specifically, on May 24, 2016, the Wall Street Journal reported investigations concerning CBL officials falsifying information on financial statements to banks when applying for financial arrangements.
IMMU: 2.80 (+0.15), HCP: 39.45 (+0.22), UNIS: 3.48 (-0.06), CBL: 12.19 (-0.10), INFI: 1.69 (+0.01), EGRX: 46.57 (+3.43), NVCN: 0.58 (+0.04)
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Eagle Pharmaceuticals, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 1, 2016 - EGRX
ACCESSWIRE - Wed Jun 15, 9:04AM CDT
NEW YORK, NY / ACCESSWIRE / June 15, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
EGRX: 46.57 (+3.43)
Law Offices of Marc S. Henzel Announces Investigation of Companies for Violations of the Federal Securities Laws
PR Newswire - Tue Jun 14, 8:11AM CDT
The Law Offices of Marc S. Henzel (www.henzellaw.com), a firm focusing on shareholder litigation, gives notice to shareholders of investigation into the following securities for violations of the Federal Securities Laws:
LDRH: 36.98 (-0.02), CBL: 12.19 (-0.10), TRXC: 1.30 (-0.05), EGRX: 46.57 (+3.43), NVCN: 0.58 (+0.04)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Eagle Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - EGRX
PR Newswire - Fri Jun 10, 4:42PM CDT
Pomerantz LLP announces that a class action lawsuit has been against Eagle Pharmaceuticals, Inc. ("Eagle Pharmaceuticals" or the "Company"
(NASDAQ: EGRX) and certain of its officers. The class action, filed in United States District Court, District of New Jersey, and docketed under 16-cv-03091, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Eagle Pharmaceuticals securities between February 23, 2016 and March 18, 2016 inclusive (the "Class Period". This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act". EGRX: 46.57 (+3.43)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Eagle Pharmaceuticals, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 1, 2016 -- EGRX
Marketwired - Fri Jun 10, 11:37AM CDT
NEW YORK, NY--(Marketwired - June 10, 2016) - The following statement is being issued by Levi & Korsinsky, LLP:
EGRX: 46.57 (+3.43)
